ライフサイエンスコーパス: fulminant

1 re non-severe, 40% were severe, and 21% were fulminant.

2 lar coagulation have been reported following fulminant A. baumannii sepsis, little is known about the

3 precisely and rapidly than ICP in pigs with fulminant ALF.

4 rior to M tuberculosis infection resulted in fulminant and disseminated disease by 8 weeks after infe

5 d by anti-PD-1/PD-L1 antibodies, can lead to fulminant and even fatal consequences and thus require e

6 ntations range from mild and self-limited to fulminant and fatal.

7 azole and oral vancomycin was common for non-fulminant and fulminant CDI, but was not associated with

8 use and effectiveness of dual therapy in non-fulminant and fulminant CDI.

9 athogen Bacillus anthracis causes anthrax, a fulminant and lethal infection of mammals.

10 Delay in surgical intervention for fulminant and medically refractory cases leads to worse

11 ms ranging from mild-to-severe diarrhoea, to fulminant and often fatal pseudomembranous colitis (PMC)

12 e that primary murine and human PMNs mount a fulminant and self-propagating neutrophil extracellular

13 nto three categories: acute mild infection, 'fulminant' and chronic hepatitis (long-term persistent f

14 Cisplatin induced fulminant apoptosis of HK-2 cells with increased caspase

15 for duration of disease, was associated with fulminant appearance (odds ratio, 1.24; 95% confidence i

16 conclude that liver damage in this model of fulminant autoimmune hepatitis is driven by CD4(+) T cel

17 whether corticosteroids improve survival in fulminant autoimmune hepatitis, drug-induced, or indeter

18 Within 48 h following aortic constriction, fulminant biventricular congestive heart failure, charac

19 ATA-1 deficiency, Cdk9 inhibition produced a fulminant but reversible megakaryoblastic disorder remin

20 n = 12), inflammatory stricture (n = 7), and fulminant C difficile colitis (n = 3).

21 In our model of fulminant cardiac allograft rejection in sensitized host

22 Risk factors for a fulminant case were exposure to clindamycin (odds ratio

23 potential use for the management of severe, fulminant cases is discussed.

24 survivors and undetectable in all six fatal fulminant cases.

25 ho were diagnosed with severe, complicated ("fulminant") CDAD and were treated at the University of P

26 the analysis was restricted to patients with fulminant CDI (aOR 1.17, 95% CI 0.65-2.10).

27 the analysis was restricted to patients with fulminant CDI (aOR, 1.17; 95% CI, .65-2.10).

28 d vancomycin was common for nonfulminant and fulminant CDI but was not associated with improved outco

29 d, germ-free C57BL/6 mice are susceptible to fulminant CDI from a BI/NAP1 strain and represent a nove

30 All cases (n = 21) of fulminant CDI had a CT-toxin(+) result.

31 dA and TcdB (designated "ABA") that reverses fulminant CDI in mice infected with an epidemic 027 stra

32 vancomycin was common for non-fulminant and fulminant CDI, but was not associated with improved outc

33 ith significant immunocompromise, history of fulminant CDI, or irreversible bleeding disorders were e

34 le FMT included inpatient status, severe and fulminant CDI, presence of pseudomembranous colitis, and

35 78% for recurrent CDI and 22% for severe or fulminant CDI.

36 iveness of dual therapy in non-fulminant and fulminant CDI.

37 tiveness of dual therapy in nonfulminant and fulminant CDI.

38 rimary amebic meningoencephalitis (PAM) is a fulminant central nervous system infection caused by the

39 with a substantially more severe and rapidly fulminant clinical course.

40 us (IV) metronidazole to oral vancomycin for fulminant Clostridioides difficile infection (CDI).

41 oration, fistula, stricture/obstruction, and fulminant Clostridium difficile colitis.

42 9 patients treated with TPE for an attack of fulminant CNS inflammatory demyelinating disease.

43 n that all Pros1-/- mice die in utero,from a fulminant coagulopathy and associated hemorrhages.

44 val [CI], 1.88 to 18.1; P = 0.002), baseline fulminant colitis (OR, 84.7; 95% CI, 14.3 to 500; P < 0.

45 Trials of tacrolimus for treatment of fulminant colitis in children have been disappointing.

46 ne severe disease by IDSA criteria, baseline fulminant colitis, and fever of >38.5 degrees C.

47 ptible mice (dnKO) that develop spontaneous, fulminant colitis, triggered by Bacteroides thetaiotaomi

48 with symptoms ranging from mild diarrhea to fulminant colitis.

49 The patient had a fulminant course leading to death within 72 h of present

50 esents the ultimate therapeutic option for a fulminant course or end-stage liver disease.

51 The patient had a fulminant course requiring emergent valve replacement.

52 ents can monitor or prevent the unexpectedly fulminant course.

53 aive male hosts, beta1AR antibodies elicited fulminant DCM at high frequency.

54 The absence of alphabeta T cells led to the fulminant death of LPS-challenged mice, coinciding with

55 ge (TPE) has been successfully used to treat fulminant demyelinating attacks unresponsive to steroids

56 and presentation ranges from asymptomatic to fulminant, depending on the characteristics of both the

57 The onset of fulminant diabetes was associated with severe lymphocyte

58 All the control animals developed fulminant disease and succumbed to the MARV challenge by

59 many questions remain, especially regarding fulminant disease associated with Plasmodium falciparum

60 f COVID-19 include asymptomatic carriers and fulminant disease characterized by sepsis and acute resp

61 an primates (NHPs) results in an accelerated fulminant disease course compared to that of naturally o

62 st that elevation of PTX3 is associated with fulminant disease during A. baumannii sepsis.

63 thy at base line or were predisposed to more fulminant disease following pressure overload stimulatio

64 at either toxin A or toxin B alone can cause fulminant disease in the hamster infection model and pre

65 ng either toxin A or toxin B alone can cause fulminant disease in the hamster model of infection.

66 s respond to skin commensal bacteria and the fulminant disease in their absence was driven by skin co

67 All three strains produced fulminant disease in this animal with a spectrum of prog

68 This fulminant disease is caused by an ENU-induced recessive

69 eumonia and, on rare occasions, manifests as fulminant disease that leads to mortality, even in healt

70 Yersinia pestis causes bubonic plague, a fulminant disease where host immune responses are abroga

71 TNF(-/-) mice succumbed to fulminant disease whereas wild-type mice, and those engi

72 age chemotactic peptide-1 were indicative of fulminant disease with >90% mortality within 48 hrs.

73 he periphery, whereas clade C FIV-C36 causes fulminant disease with CD4(+) T-cell depletion and neutr

74 FV infected IFNAR(-/-) mice develop an acute fulminant disease with high viral loads leading to organ

75 festation of clinical disease and clinically fulminant disease, as well as cell infiltrate, resolved

76 reptococcus pyogenes, in addition to causing fulminant disease, can be carried asymptomatically and m

77 In fulminant disease, increased IL-1 signaling resulted in

78 In addition to causing fulminant disease, Streptococcus pyogenes may be asympto

79 aganglionosis in patients with end-stage or fulminant disease.

80 y modified animals, and because they develop fulminant disease.

81 pproximately 9,000 organisms leads to acute, fulminant disease.

82 cases in which patients begin treatment for fulminant disease.

83 gration into the GI tract where they mediate fulminant disease.

84 Four patients presented with fulminant, disseminated PTLD; only one of these four pat

85 egional burden of lesions, indicating a more fulminant dissemination of pTDP-43 pathology.

86 ganisms range from acute watery diarrhoea to fulminant dysentery characterised by frequent scant bloo

87 b blockade of both B7-1 and B7-2 resulted in fulminant, early-onset neuropathy.

88 , amnestic (1 patient), and a severe form of fulminant encephalitis (2 patients).

89 ptic (1 patient), amnestic (3 patients), and fulminant encephalitis (2 patients).

90 as and higher incidence of neuroinvasion and fulminant encephalitis seen in the young, and may also e

91 (NSV) is a neuronotropic virus that causes a fulminant encephalomyelitis in susceptible mice due to d

92 crotizing encephalopathy (ANE) presents with fulminant encephalopathy and characteristic brain lesion

93 atal lethality in mice, primarily because of fulminant epilepsy.

94 ated with disruption of colonic homeostasis, fulminant epithelial/tumor cell proliferation, and activ

95 vitamin D levels above 200 nmol/l developed fulminant experimental autoimmune encephalomyelitis with

96 Cholestatic disease and fulminant failure were highest in group A and those <5 k

97 cult to predict whether a patient with acute fulminant failure will recover spontaneously.

98 ne knockout background, POT mice developed a fulminant form of peripheral neuropathy that affected al

99 e disorders (MPDs), either transient or more fulminant forms, can also occur in infants with NS (NS/M

100 s, granulomatous fungal sinusitis, and acute fulminant fungal rhinosinusitis.

101 he course of his EBV infection and died from fulminant gram-positive bacterial sepsis.

102 ited human IL-18BP deficiency thus underlies fulminant HAV hepatitis by unleashing IL-18.

103 The poly(U/UC) region of the fulminant HCV JFH-1 strain was a relatively weak activat

104 to be susceptible to infection with another fulminant HCV strain (JFH1).

105 iant cell myocarditis (GCM) typically causes fulminant heart failure, arrhythmias, or heart block, ne

106 lated with severe myocardial dysfunction and fulminant heart failure.

107 ce of healthy residual liver mass, otherwise fulminant hepatic failure (FHF) may arise.

108 n is the only proven effective treatment for fulminant hepatic failure (FHF), but its use is limited

109 antation (OLT) is an effective treatment for fulminant hepatic failure (FHF), but postOLT mortality i

110 Death occurs in half of all children with fulminant hepatic failure (FHF).

111 homas may involve the liver but rarely cause fulminant hepatic failure (FHF).

112 outcomes following liver transplantation in fulminant hepatic failure (FHF).

113 d experimental protocol of LPS-induced acute fulminant hepatic failure (i.p. injection of low dose of

114 Candidates with fulminant hepatic failure (Status-1A) receive the highes

115 on communication to prevent amplification of fulminant hepatic failure and acetaminophen-induced hepa

116 riceal bleeding, as well as in patients with fulminant hepatic failure and alcoholic hepatitis.

117 ls are beginning to acknowledge subgroups of fulminant hepatic failure and properly randomize therapy

118 ce nodularity is commonly seen at imaging in fulminant hepatic failure and usually reflects a combina

119 who was transferred to our institution with fulminant hepatic failure and worsening hepatic encephal

120 y patients who die from paracetamol overdose fulminant hepatic failure as accurately as King's Colleg

121 ars) who underwent liver transplantation for fulminant hepatic failure at our institution during a 5-

122 Patients diagnosed with fulminant hepatic failure face high mortality rates.

123 s into a bioartificial liver device to treat fulminant hepatic failure improved animal survival, ther

124 er, the hepatocyte-like cells rescued lethal fulminant hepatic failure in a nonobese diabetic severe

125 ied strain HC-TN (genotype 1a), which caused fulminant hepatic failure in a patient and, subsequently

126 ute, self-limiting liver disease that causes fulminant hepatic failure in specific high-risk groups o

127 The management of patients with fulminant hepatic failure is a major clinical endeavor.

128 be included in the differential diagnosis of fulminant hepatic failure of unknown pathogenesis.

129 No fulminant hepatic failure or death was observed.

130 Patients with fulminant hepatic failure should be stabilized and trans

131 major complications of acute liver failure (fulminant hepatic failure) and a major cause of death in

132 liver disease ranging from acute (including fulminant hepatic failure) to chronic hepatitis, cirrhos

133 Eight (33%) patients with fulminant hepatic failure, 97 (66%) patients with chroni

134 ver transplantation if they have evidence of fulminant hepatic failure, a life-threatening systemic c

135 Patients dying of fulminant hepatic failure, for whom no alternative thera

136 Although rare, HSV-1 can also cause fulminant hepatic failure, which is often fatal.

137 liver allotransplantation for patients with fulminant hepatic failure.

138 ut may lead to acute hepatitis and rarely to fulminant hepatic failure.

139 traumatic brain injury, ischemic stroke, and fulminant hepatic failure.

140 pper limit of normal but almost never causes fulminant hepatic failure.

141 terial peritonitis, hepatorenal syndrome, or fulminant hepatic failure.

142 anges from mild elevations in liver tests to fulminant hepatic failure.

143 ped as follows: a) chronic liver failure; b) fulminant hepatic failure; c) patients immediately statu

144 Many of these agents produce fulminant hepatic necrosis and, in some cases, were with

145 Fulminant hepatitis (FH) is a disease characterized by m

146 The two prolines (P310 and P341 of Japanese fulminant hepatitis 1 [JFH-1]) contained in these motifs

147 that the H316N mutation rendered a Japanese fulminant hepatitis 1 chimeric HCV genome encoding the g

148 human hepatocytes infected with the Japanese fulminant hepatitis 1 HCV strain as well as in biopsies

149 cells, and approximately 90% in J6/Japanese fulminant hepatitis 1 HCV-infected cells without affecti

150 icon cells, approximately 70% in J6/Japanese fulminant hepatitis 1 HCV-transfected cells, and approxi

151 patient developed possibly treatment-related fulminant hepatitis 6 weeks after IPH4102 discontinuatio

152 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit N

153 Infantile fulminant hepatitis developed in 1 of 1050 children who

154 ine hepatitis virus strain-3 (MHV-3)-induced fulminant hepatitis due to excessive macrophage-dependen

155 the severity of peritoneal inflammation and fulminant hepatitis in mice.

156 duced lethality following endotoxin-mediated fulminant hepatitis in mice.

157 oimmune hepatitis can present as an acute or fulminant hepatitis in the absence of pre-existent fibro

158 mortality in an LPS/d-galactosamine-induced fulminant hepatitis mouse model.

159 ore-severe acute peritoneal inflammation and fulminant hepatitis than control mice.

160 nomic replicon cells or genotype 2a Japanese fulminant hepatitis type 1 (JFH-1) virus-infected hepato

161 We show that viral production of Japanese fulminant hepatitis type 1 increases 1,000-fold when cel

162 h-titer infectious virus as well as Japanese fulminant hepatitis type 1, H77/C3, and Con1/C3.

163 f severe end-stage liver diseases and infant fulminant hepatitis were significantly lower in the vacc

164 2%) were admitted to hospital, two developed fulminant hepatitis, and one needed a liver transplant;

165 No major liver-related complications (e.g., fulminant hepatitis, decompensated liver, and hepatocell

166 ent populations of immune cells and Japanese fulminant hepatitis-1 (JFH-1) HCV-infected Huh7.5 (cell

167 ted/founder virus, sucrose-purified Japanese fulminant hepatitis-1 (JFH-1), a virus encoding a lucife

168 When HCV Japanese fulminant hepatitis-1 (JFH-1)-infected hepatocytes were

169 and primary human hepatocytes with Japanese fulminant hepatitis-1 (JFH1) HCV cell culture system (HC

170 The Japanese fulminant hepatitis-1 (JFH1)-based hepatitis C virus (HC

171 also protected mice from endotoxin shock and fulminant hepatitis.

172 c HBV infection, but might prevent infantile fulminant hepatitis.

173 cies other than hepatocellular carcinoma and fulminant hepatitis.

174 genotype 2a strain JFH-1 from a patient with fulminant hepatitis.

175 amined in two models: LPS-induced sepsis and fulminant hepatitis.

176 sig4 in mice ameliorates MHV-3-induced viral fulminant hepatitis.

177 cessive copper accumulation in the liver and fulminant hepatitis.

178 cetaminophen-induced liver toxicity, causing fulminant hepatocellular injury.

179 following variables: age>65 years, severe or fulminant illness (by the Horn index), and additional an

180 sfer of wt MDSCs was capable of reducing the fulminant immune-mediated liver damage in cremtg mice to

181 ghly motile spirochete that causes acute and fulminant infections in humans and other accidental host

182 NA) can be detected from blood plasma during fulminant infections such as sepsis.

183 nd often fatal, clinical sequelae, including fulminant infectious mononucleosis, hemophagocytic lymph

184 e present for Aire-deficient mice to develop fulminant infiltrates.

185 Fulminant inflammation in the liver is often accompanied

186 ial burdens that are usually associated with fulminant inflammatory disease in normal hosts.

187 manifestations ranging from simple fever to fulminant inflammatory diseases with high mortality rate

188 pression of T cells during TB as well as the fulminant inflammatory response that can compromise T-ce

189 t of influenza symptoms predicted death from fulminant influenza (P = 0.04).

190 al cases to shed light on this recurrent and fulminant irAE.

191 MRSA causes fulminant keratitis often requiring surgical management

192 e virus, was isolated in cell culture from a fulminant lethal case of hantavirus disease presenting w

193 invasive pneumococcal infection resulting in fulminant, lethal pneumococcal sepsis.

194 ce of waiting list registration for ESLD and fulminant liver disease decreased, whereas that for HCC

195 ther) and by indication for transplantation (fulminant liver disease, hepatocellular carcinoma [HCC],

196 The patient died due to fulminant liver failure 14 months later; the histopathol

197 massive hepatocyte apoptosis and subsequent fulminant liver failure and death in D-GalN-sensitized m

198 r transplantation (LT) between patients with fulminant liver failure and those with cirrhosis and sev

199 h is frequently up-regulated in HCCs, delays fulminant liver failure in mice by inhibiting apoptosis,

200 SCs) protect from death in a lethal model of fulminant liver failure induced by intraperitoneal injec

201 These data suggest that fulminant liver failure may potentially benefit from tre

202 ed liver injury has been described involving fulminant liver failure or death.

203 or definite AIH) among the 70 patients with fulminant liver failure was 24% for simplified criteria

204 cluding a subset of patients presenting with fulminant liver failure who required liver transplant.

205 DNA, but not control non-CpG DNA, induces a fulminant liver failure with subsequent shock-mediated d

206 nt treatment also prevents TNFalpha-mediated fulminant liver failure without affecting liver regenera

207 pression can lead to severe acute hepatitis, fulminant liver failure, and death.

208 dinedione sometimes, although rarely, led to fulminant liver failure, and ultimately the drug was rem

209 is currently the only effective therapy for fulminant liver failure, but its use is limited by the s

210 nitive treatment for end-stage cirrhosis and fulminant liver failure, but the lack of available donor

211 rosis factor (TNF)-mediated murine models of fulminant liver failure.

212 tation is wide, varying from mild disease to fulminant liver failure.

213 neurological disability, then developed sub-fulminant liver failure.

214 or patients with decompensated cirrhosis and fulminant liver failure.

215 and lipopolysaccharide (LPS) model of acute, fulminant liver injury dramatically decreased serum alan

216 ent mice are resistant to the development of fulminant liver injury upon lipopolysaccharide administr

217 ll three animal groups ameliorated otherwise fulminant liver injury, as evidenced by depressed serum

218 Acetaminophen (APAP) overdose causes severe, fulminant liver injury.

219 ould be beneficial clinically to limit acute fulminant liver pathologies.

220 patient who is admitted urgently with acute (fulminant) liver failure in whom consent may not be poss

221 not those that received 2 x 10(6), developed fulminant macrophage pneumonia with eosinophilia, Ym1 de

222 These data demonstrate that both fulminant MAS and hemophagocytosis can arise independent

223 Fulminant MAS was characterized by dramatic elevations i

224 odel of Toll-like receptor 9 (TLR-9)-induced fulminant MAS.

225 y and in high concentrations, they may cause fulminant MC degranulation and anaphylaxis.

226 persons in the blood prior to development of fulminant meningitis and preemptive treatment for CrAg-p

227 cted via circulating antigen in blood before fulminant meningitis develops, when early antifungal the

228 in vivo, we set up an experimental model of fulminant meningococcemia in human skin grafted SCID mic

229 ellation of findings usually associated with fulminant meningococcemia.

230 e, in collaboration with H-RAS, BMI1 induced fulminant metastatic disease in the lung using a tail ve

231 cal and environmental stressors that trigger fulminant MH and promote myopathy.

232 sceptibility and possibly contributes to the fulminant MH episode.

233 tate the loss of Ca2+ control that defines a fulminant MH event.

234 t stress at 41 degrees C invariably triggers fulminant MH in Hom, but not Het, mice within 20 min.

235 et females and 100% of the Het males develop fulminant MH within 40 min.

236 either sex and 17% of the Het males develop fulminant MH.

237 brillar beta-amyloid (Abeta) in the brain, a fulminant microglial-mediated inflammatory reaction, and

238 of antibiotic treatment in the outcome of a fulminant model of CLP.

239 fts delayed the onset and progression of the fulminant motor neuron disease typical of the rat SOD1 G

240 hich are mainly found in patients with acute fulminant multiple sclerosis with Balo's type concentric

241 cal analysis of STIM1 transgenic mice showed fulminant muscle disease characterized by myofiber necro

242 Fulminant myocarditis (FM) is an uncommon syndrome chara

243 e their dramatic presentation, patients with fulminant myocarditis (FM) might have better outcome tha

244 All tissue samples from fulminant myocarditis (n=2) and GCM (n=13) contained hum

245 Treatment of viral fulminant myocarditis relies on life support measures.

246 A 36-year-old woman who was hospitalized for fulminant myocarditis with biventricular failure and car

247 ients (27%) had GCM and 4 patients (13%) had fulminant myocarditis.

248 uces acute respiratory distress syndrome and fulminant myocarditis.

249 hat anakinra may be a suitable treatment for fulminant myocarditis.

250 BAG3-deficient animals developed a fulminant myopathy characterized by noninflammatory myof

251 es, and its targeted deletion in mice causes fulminant myopathy with early lethality.

252 in universal mortality in conjunction with a fulminant necrotizing hepatitis.

253 scular hemorrhage in the lung in addition to fulminant necrotizing pneumonia caused by massive bacter

254 Knockout (KO) of CSPalpha causes fulminant neurodegeneration that is rescued by alpha-syn

255 , mutant mice invariably developed a rapidly fulminant neurological decline characterized by ataxia,

256 9 has been implicated in some cases of acute fulminant non-A, non-B, non-C, non-G liver failure.

257 All eyes had a fulminant onset within the first 24 hours of cataract su

258 tion of TLR2 in MDR1A deficiency resulted in fulminant pancolitis with early expansion of CD11b(+) my

259 22Q, presenting with severe myotonia without fulminant paralytic episodes.

260 We present a case of fulminant Pasteurella multocida sepsis in a 66-year-old

261 own, and no effective therapies for treating fulminant pertussis exist.

262 Patients who progressed to the fulminant phase had a mortality rate of 97% (regardless

263 Despite advances in supportive care, fulminant-phase inhalational anthrax is usually fatal.

264 th effects ranging from chronic abscesses to fulminant pneumonia and septic shock, which can be rapid

265 enza virus in cynomolgus macaques results in fulminant pneumonia that rapidly progresses to acute res

266 int Y. pestis gained the ability to induce a fulminant pneumonia.

267 ate rapidly in the airways, causing a lethal fulminant pneumonia; if unexpressed, inflammation is abo

268 with bacterial growth and the development of fulminant pneumonic and septicemic plague.

269 A fulminant presentation that is associated with de novo r

270 The mechanisms responsible for this fulminant process remain unknown; we hypothesized that t

271 The fulminant progression of disease has been largely ascrib

272 treated patients relapse with resistance and fulminant progression.

273 EV1 and FVC decline identifies patients with fulminant, rapid deterioration and is the strongest clin

274 ressive agents were prone to more severe and fulminant recurrent disease.

275 Indeed, cardiac allografts underwent fulminant rejection in sensitized BKO, albeit with somew

276 mem function in the sensitization phase, the fulminant rejection of cardiac allografts was B-cell-ind

277 grafts on group 3 and group 4 animals led to fulminant rejection of heart and skin grafts, in contras

278 thic pneumonia." The infection may result in fulminant respiratory decompensation and shock after tra

279 sentation, ranging from silent infections to fulminant respiratory disease and dissemination.

280 range of symptoms ranging from mild through fulminant respiratory failure.

281 racellular Burkholderia In a murine model of fulminant respiratory melioidosis, treatment with BFX or

282 that received a nonspecific vector developed fulminant SEBOV hemorrhagic fever and succumbed.

283 Clinical manifestations range from acute fulminant sepsis to chronic infection mimicking tubercul

284 e puncture (2CLP) was used to model mild and fulminant sepsis, respectively.

285 w-organ perforation leads to peritonitis and fulminant sepsis.

286 m mild dehydration due to gastroenteritis to fulminant septic shock, requires careful assessment and

287 ion exacerbates and accelerates the onset of fulminant sHLH, in which systemic hemophagocytosis, hype

288 ients progress to a severe, complicated, or "fulminant" state of life-threatening systemic toxicity.

289 eltamucin)lpr mice developed accelerated and fulminant systemic autoimmunity with accumulation of abn

290 wide range of disease, from mild diarrhea to fulminant systemic disease.

291 is of inhalation anthrax before the onset of fulminant systemic infection.

292 ocytosis, is the dominant cause of anemia in fulminant TLR-9-induced MAS.

293 Disease severity varied from fulminant to minimal in accordance with the challenge do

294 Fulminant viral hepatitis (FVH) is a devastating and une

295 Fulminant viral hepatitis occurs in a very small number

296 ctile dysfunction, we treated a patient with fulminant viral myocarditis with the interleukin-1 recep

297 Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normall

298 remission in patients with recalcitrant and fulminant, vision-threatening ocular inflammatory disord

299 and a likelihood ratio of 23 for diagnosing fulminant WD.

300 , and a likelihood ratio of 7 for diagnosing fulminant WD.